WFIRM announcement of a new Innovation Accelerator company – PHC – and a new endeavor called the Clinical Trials Catalyst that will involve two PHC companies, led by ReMDO and WFIRM. Speakers: Gary Green, CEO ReMDO, Anthony Atala, Director WFIRM, Steven Lynum, President of Epredia a division of PHC which is based out of Japan, Eric His, Pathology Chair and Terry Hales, MBA. Held in the collaboration area on 2nd floor Dean Building.
Regenerative Medicine Manufacturing Society (RMMS) is partnering with STEM CELLS Translational Medicine to build a freely accessible collection of shared resources across three areas: models; cell therapies; and technologies. These resources will bring together the scientific community and highlight how the field of regenerative medicine is uniquely positioned to fight the COVID-19 pandemic.
Medical Device Developments published an article titled “A helping hand” featuring ReMDO CTO Joshua Hunsberger in a Q&A about 3D bioprinting.
February 24, 2020 – Webinar: Gaps and Opportunities for Fighting COVID-10 featuring Dr. Anthony Atala (WFIRM): Regenerative Medicine Tools to Fight COVID, Dr. Martha Lundberg (NHLBI, NIH): NHLBI Efforts for Fighting COVID, Dr. Lucie Low (NCATS, NIH): NCATS Efforts for Fighting COVID, Dr. Mahendra Rao (NYSCF): NYSCF Efforts for Fighting COVID, and Dr. Maria Millan (CIRM): CIRM Efforts for Fighting COVID. Click here to view the full recording.
Key Meeting Archive
June 2021—RegMIC & RMMS collocated with RME and WSCS)
January 21, 2020—RMMS (collocated with WSCS)
May 15, 2019—RegMIC
January 22, 2019—RMMS (co-located with WSCS)
May 8, 2018—RegMIC
January 26, 2018—RMMS (co-located with WSCS)
June 13, 2017—RegMIC
July 18, 2016—RegMIC
February 25, 2016—RegMIC
August 27, 2015—RegMIC
May 20, 2015 Charlotte NC—RegMIC
May 5-7, 2014 Regenerative Medicine Foundation 2014 Conference